ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,354.05
0.49%
Dow Jones
39,056.39
0.44%
Gold vs US Dollar
2,313.955
0.25%
Brent Oil
83.72
0.19%
Bitcoin
61,566.37
0.62%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Mallinckrodt Plc (MNK)

  7. Mallinckrodt Plc (MNK) News

Mallinckrodt (MNK)

Mallinckrodt Plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:MNK
DateTimeSourceHeadlineSymbolCompany
26/03/202420:01PR Newswire (US)Mallinckrodt plc Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides 2024 GuidanceNYSE:MNKMallinckrodt Plc
11/03/202410:52PR Newswire (US)Mallinckrodt Announces Journal Publication of Real-World Data on Acthar® Gel (repository corticotropin injection) to Treat Symptomatic Sarcoidosis in African American and Non-African American PatientsNYSE:MNKMallinckrodt Plc
04/03/202411:45PR Newswire (US)Mallinckrodt Announces Appointment of Paul O'Neill as Executive Vice President, Quality & Operations, Specialty BrandsNYSE:MNKMallinckrodt Plc
01/03/202413:50PR Newswire (US)Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ InjectorNYSE:MNKMallinckrodt Plc
02/02/202413:45PR Newswire (US)Mallinckrodt Announces Board of Directors and Leadership UpdatesNYSE:MNKMallinckrodt Plc
22/01/202411:52PR Newswire (US)Mallinckrodt Presents New Data on TERLIVAZ® (terlipressin) for Injection at the Society of Critical Care Medicine (SCCM) 2024 Critical Care CongressNYSE:MNKMallinckrodt Plc
01/11/202310:45PR Newswire (US)Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2023 Scientific MeetingNYSE:MNKMallinckrodt Plc
26/10/202311:53PR Newswire (US)Mallinckrodt Presents Latest Health Economics Data on Acthar® Gel (Repository Corticotropin Injection) at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023NYSE:MNKMallinckrodt Plc
30/08/202316:54PR Newswire (US)Mallinckrodt Receives Court Approval for "First Day" Motions to Support Ongoing OperationsNYSE:MNKMallinckrodt Plc
29/06/202323:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:MNKMallinckrodt Plc
29/06/202323:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:MNKMallinckrodt Plc
29/06/202323:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:MNKMallinckrodt Plc
29/06/202323:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:MNKMallinckrodt Plc
29/06/202323:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:MNKMallinckrodt Plc
29/06/202323:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:MNKMallinckrodt Plc
29/06/202323:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:MNKMallinckrodt Plc
29/06/202323:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:MNKMallinckrodt Plc
27/06/202300:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:MNKMallinckrodt Plc
26/06/202311:48Edgar (US Regulatory)Current Report Filing (8-k)NYSE:MNKMallinckrodt Plc
23/06/202321:43Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:MNKMallinckrodt Plc
23/06/202311:53Edgar (US Regulatory)Current Report Filing (8-k)NYSE:MNKMallinckrodt Plc
20/06/202311:49Edgar (US Regulatory)Current Report Filing (8-k)NYSE:MNKMallinckrodt Plc
16/06/202322:05Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NYSE:MNKMallinckrodt Plc
16/06/202317:28Edgar (US Regulatory)Current Report Filing (8-k)NYSE:MNKMallinckrodt Plc
05/06/202311:31Edgar (US Regulatory)Current Report Filing (8-k)NYSE:MNKMallinckrodt Plc
31/05/202321:07Edgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:MNKMallinckrodt Plc
30/05/202321:32Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:MNKMallinckrodt Plc
30/05/202321:17Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:MNKMallinckrodt Plc
17/05/202321:07Edgar (US Regulatory)Current Report Filing (8-k)NYSE:MNKMallinckrodt Plc
09/05/202311:52Edgar (US Regulatory)Quarterly Report (10-q)NYSE:MNKMallinckrodt Plc
 Showing the most relevant articles for your search:NYSE:MNK

Your Recent History

LSE
ALBA
Alba Mineral Resources
LSE
GGP
Greatland Gold
LSE
SCE
Surface Transforms
LSE
GKP
Gulf Keystone Petroleum
LSE
ITV
Itv
LSE
BIRD
Blackbird
LSE
EDEN
Eden Research
LSE
RBG
Revolution Bars
LSE
JEMA
Jpmorgan Emerging Europe...
LSE
CHAR
Chariot
LSE
CEG
Challenger Energy
LSE
INSP
Inspirit Energy
LSE
NSCI
Netscientific
LSE
AT.
Ashtead Technology
LSE
IGR
Ig Design
LSE
NIOX
Niox
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved